CA2660717A1 - Methods for lymph system imaging - Google Patents

Methods for lymph system imaging Download PDF

Info

Publication number
CA2660717A1
CA2660717A1 CA002660717A CA2660717A CA2660717A1 CA 2660717 A1 CA2660717 A1 CA 2660717A1 CA 002660717 A CA002660717 A CA 002660717A CA 2660717 A CA2660717 A CA 2660717A CA 2660717 A1 CA2660717 A1 CA 2660717A1
Authority
CA
Canada
Prior art keywords
region
contrast agent
image
mammal
node
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002660717A
Other languages
English (en)
French (fr)
Inventor
Vincent Jacques
Peter D. Caravan
Bernd Misselwitz
Hanns-Joachim Weinmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lantheus Medical Imaging Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2660717A1 publication Critical patent/CA2660717A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Signal Processing (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
CA002660717A 2006-08-17 2007-08-16 Methods for lymph system imaging Abandoned CA2660717A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83848806P 2006-08-17 2006-08-17
US60/838,488 2006-08-17
PCT/US2007/076109 WO2008022263A2 (en) 2006-08-17 2007-08-16 Methods for lymph system imaging

Publications (1)

Publication Number Publication Date
CA2660717A1 true CA2660717A1 (en) 2008-02-21

Family

ID=39083140

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002660717A Abandoned CA2660717A1 (en) 2006-08-17 2007-08-16 Methods for lymph system imaging

Country Status (7)

Country Link
US (1) US20080044358A1 (enExample)
EP (1) EP2053968A4 (enExample)
JP (1) JP5563299B2 (enExample)
KR (1) KR101336505B1 (enExample)
CN (1) CN101528124A (enExample)
CA (1) CA2660717A1 (enExample)
WO (1) WO2008022263A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090024022A1 (en) * 2006-10-25 2009-01-22 Siemens Corporate Research, Inc. System and method for lymph node imaging using co-registration of ct and mr imagery
US10076264B2 (en) 2013-03-31 2018-09-18 Case Western Reserve University System and method for quantitative magnetic resonance (MR) analysis using T1 mapping
US9747789B2 (en) * 2013-03-31 2017-08-29 Case Western Reserve University Magnetic resonance imaging with switched-mode current-source amplifier having gallium nitride field effect transistors for parallel transmission in MRI
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN110035996B (zh) 2016-11-28 2022-08-09 拜耳医药股份公司 用于磁共振成像的新型高弛豫性钆螯合物
JOP20210114A1 (ar) 2018-11-23 2023-01-30 Bayer Ag تركيبة وسط تباين وعملية لتحضيرها
WO2020163286A1 (en) * 2019-02-04 2020-08-13 Massachusetts Institute Of Technology Systems and methods for lymph nodes and vessels imaging
WO2023177683A1 (en) * 2022-03-14 2023-09-21 The Board Of Trustees Of The Leland Stanford Junior University Devices, systems, and methods for treating volume overload

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0289304A (ja) * 1988-09-27 1990-03-29 Kitamura Kiden Kk 巻鉄心用帯材の切抜方法
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5843399A (en) * 1990-04-06 1998-12-01 Schering Aktiengesellschaft DTPA monoamides for MRI
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
EP0654973A4 (en) * 1992-07-21 1995-08-09 Gen Hospital Corp ARRANGEMENT FOR DELIVERING MEDICINES TO THE LYMPHIC TISSUE.
GB9216082D0 (en) * 1992-07-28 1992-09-09 Univ Nottingham Lymphatic delivery composition
TW319763B (enExample) * 1995-02-01 1997-11-11 Epix Medical Inc
DE19525924A1 (de) * 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
JPH10120597A (ja) * 1996-10-22 1998-05-12 Eiken Chem Co Ltd リンパ節高集積性コロイド粒子
DE69819925T2 (de) * 1997-10-02 2004-09-02 Epix Medical, Inc., Cambridge Kontrastverstärktes Diagnosebildererzeugungsverfahren zur Überwachung von therapeutischen Eingriffen
US6444192B1 (en) * 1999-02-05 2002-09-03 The Regents Of The University Of California Diagnostic imaging of lymph structures
AU5270500A (en) * 1999-05-14 2000-12-05 Regents Of The University Of California, The Macromolecular carrier for drug and diagnostic agent delivery
US6652835B1 (en) * 1999-07-29 2003-11-25 Epix Medical, Inc. Targeting multimeric imaging agents through multilocus binding
DE19948651B4 (de) * 1999-09-29 2006-10-05 Schering Ag Para- und diamagnetische perfluorhaltige Verbindungen enthaltende galenische Formulierungen, deren Herstellung und Verwendung
US6818203B2 (en) * 2000-08-11 2004-11-16 Schering Aktiengesellschaft Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses
US7160535B2 (en) * 2001-10-31 2007-01-09 Bracco International Bv Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
US6549798B2 (en) * 2001-02-07 2003-04-15 Epix Medical, Inc. Magnetic resonance angiography data
US6705476B2 (en) * 2001-08-22 2004-03-16 Central Metal Products, Inc. Shipping rack with torsionally loaded shelf
US20050171424A1 (en) * 2004-01-13 2005-08-04 The Gov. Of The Usa As Rep. By The Secretary Of The Dept. Of Health And Human Services Methods for imaging the lymphatic system using dendrimer-based contrast agents
US8097283B2 (en) * 2004-01-15 2012-01-17 Mount Sinai School Of Medicine Methods and compositions for imaging

Also Published As

Publication number Publication date
EP2053968A4 (en) 2015-10-21
EP2053968A2 (en) 2009-05-06
JP5563299B2 (ja) 2014-07-30
CN101528124A (zh) 2009-09-09
KR20090045343A (ko) 2009-05-07
WO2008022263A3 (en) 2008-12-11
WO2008022263A2 (en) 2008-02-21
US20080044358A1 (en) 2008-02-21
KR101336505B1 (ko) 2013-12-05
JP2010501009A (ja) 2010-01-14

Similar Documents

Publication Publication Date Title
AU742438B2 (en) Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
Kiessling et al. Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging
Lohrke et al. Preclinical profile of gadoquatrane: a novel tetrameric, macrocyclic high relaxivity gadolinium-based contrast agent
US20080044358A1 (en) Methods for lymph system imaging
Wu et al. Peptide targeted high-resolution molecular imaging of prostate cancer with MRI
de Sousa et al. In vivo MRI assessment of a novel GdIII‐based contrast agent designed for high magnetic field applications
Baek et al. High-performance hepatobiliary dysprosium contrast agent for ultra-high-field magnetic resonance imaging
US20050171424A1 (en) Methods for imaging the lymphatic system using dendrimer-based contrast agents
Boschi et al. Tumor microvasculature observed using different contrast agents: a comparison between Gd-DTPA-Albumin and B-22956/1 in an experimental model of mammary carcinoma
WO1996010359A1 (en) Chelate complex with high conspicuity for magnetic resonance imaging
JP4786112B2 (ja) 金属イオンキレート化錯体と共役させた胆汁酸誘導体の微小血管の診断評価のための使用
Zhou et al. Comparison of Gd [DTPA‐bis (2‐aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: Experimental study with rabbits
CA2271735C (en) Magnetic resonance blood pool agents
Morelli et al. Evaluation of gadodiamide versus gadobutrol for contrast-enhanced MR imaging in a rat brain glioma model at 1.5 and 3 T
Morelli et al. Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model
Chandrasekharan et al. Pharmacokinetics of Gd (DO3A‐Lys) and MR imaging studies in an orthotopic U87MG glioma tumor model
HK1131533A (en) Methods for lymph system imaging
Wu et al. MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent
Dupas et al. Delineation of liver necrosis using double contrast‐enhanced MRI
Runge et al. Magnetic resonance contrast agents in neuroimaging: New agents and applications
KR20250158760A (ko) 콜라겐 및 피브린 영상화를 위한 조영제
Yongmin The Comparative Imaging Study on Mn-phthalocyanine and Mangafodipir trisodium in Experimental VX2 Animal Model
Daldrup-Link et al. Carboxymethyldextran-A2-Gd-DOTA enhancement patterns in the abdomen and pelvis in an animal model
Vogl Contrast Media
Lu et al. Noninvasive visualization of in vivo drug delivery of paramagnetic polymer conjugates with MRI

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20160804